What is going on with jaguar health stock today?
JAGX Stock Alert: What Is Going on With Jaguar Health Today? Shares of Jaguar Health (NASDAQ:JAGX) are up 10% today after a regulatory filing revealed that prominent merchant banking firm Oasis Capital has a 10% stake in the biopharmaceutical company.
Does jagx stock pay dividends?
Restricted stock typically is that issued to company insiders with limits on when it may be traded. A company's dividend expressed as a percentage of its current stock price. JAGX is not currently paying a regular dividend. The total number of shares of a security that have been sold short and not yet repurchased.
What is your prediction for the jagx breakout?
JAGX is a nice breakout after 4 touches the trendline and trading at $1.75. My prediction in the short term is that JAGX would reach $2.65 next week (around 50% gain), set STOP LOSS below $1.58 (around 10% loss).
Is jagx a good play for PT1?
Exit PT1: 2.50 (2-4 weeks) This is the short-term play. JAGX is a nice breakout after 4 touches the trendline and trading at $1.75. My prediction in the short term is that JAGX would reach $2.65 next week (around 50% gain), set STOP LOSS below $1.58 (around 10% loss).
Should I buy JAGX stock?
The consensus among 1 Wall Street analyst covering (NASDAQ: JAGX) stock is to Strong Buy JAGX stock.
Will JAGX go up?
Jaguar Health Inc (NASDAQ:JAGX) The 1 analysts offering 12-month price forecasts for Jaguar Health Inc have a median target of 5.00, with a high estimate of 5.00 and a low estimate of 5.00. The median estimate represents a +1,412.40% increase from the last price of 0.33.
Why did Jaguar Health stock drop so much?
What's Going On With Jaguar Health? Jaguar Health (JAGX) stock fell amid panic selling after the company announced a 1-for-3 reverse stock split, which was approved by majority of common stock shareholders in December 2020. Shares of the company were trading lower -18.96% to $0.94 a share on Tuesday.
What's the price of Jaguar health?
$0.3170$ 0.3200CloseChgChg %$0.3170-0.0119-3.62%
Is Jaguar health going out of business?
Based on the latest financial disclosure, Jaguar Health has a Probability Of Bankruptcy of 93%. This is 114.83% higher than that of the Healthcare sector and 69.58% higher than that of the Biotechnology industry.
What is JAGX?
SAN FRANCISCO, CA / ACCESSWIRE / July 1, 2022 / Jaguar Health, Inc. (NASDAQ:JAGX) ("Jaguar" or the "Company") today announced that, effective June 27, 2022 , the Company granted 60,000 restricted stock units (RSUs) to New Employee 1 and 12,500 RSUs to New Employee 2.
Who is JAGX merging with 2021?
The Merger of Jaguar Animal Health and Napo Pharmaceuticals is Effective. The Combined Company's New Name is Jaguar Health, Inc.
Did JAGX do a reverse split?
The first split for JAGX took place on June 01, 2018. This was a 1 for 15 reverse split, meaning for each 15 shares of JAGX owned pre-split, the shareholder now owned 1 share. For example, a 1000 share position pre-split, became a 66.6666666666667 share position following the split.
What happened with Jaguar stock?
Over the past few years, on a split-adjusted basis, JAGX stock has imploded, plunging from more than $1,000 per share to just $3.21 now. However, the ailing company has looked a little healthier at the beginning of 2021. JAGX stock has leapt back from under a dollar per share to its current level.
How much is Lamborghini stock?
Performance OutlookPrevious Close0.0550Bid0.0500 x 0Ask0.0550 x 0Day's Range0.0500 - 0.060052 Week Range0.0400 - 0.37503 more rows
Who owns Jaguar now?
Tata MotorsBritish Motor HoldingsJaguar Cars/Parent organizations
What is the share price of Fastrack?
NSEOPEN1.80DAY LOW1.80PREVIOUS CLOSE1.80VOLUME1000052-WEEK HIGH1.807 more rows
Should I buy or sell Jaguar Health stock right now?
1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Jaguar Health in the last twelve months. There are currently 1 buy rating...
What is Jaguar Health's stock price forecast for 2022?
1 brokers have issued 1-year price targets for Jaguar Health's stock. Their JAGX stock forecasts range from $5.00 to $5.00. On average, they expect...
How has Jaguar Health's stock price performed in 2022?
Jaguar Health's stock was trading at $1.04 at the start of the year. Since then, JAGX stock has decreased by 67.2% and is now trading at $0.3412....
When is Jaguar Health's next earnings date?
Jaguar Health is scheduled to release its next quarterly earnings announcement on Friday, August 12th 2022. View our earnings forecast for Jaguar...
How were Jaguar Health's earnings last quarter?
Jaguar Health, Inc. (NASDAQ:JAGX) issued its quarterly earnings data on Tuesday, May, 10th. The biotechnology company reported ($0.40) earnings per...
When did Jaguar Health's stock split? How did Jaguar Health's stock split work?
Shares of Jaguar Health reverse split on the morning of Wednesday, September 8th 2021. The 1-3 reverse split was announced on Wednesday, September...
Who are Jaguar Health's key executives?
Jaguar Health's management team includes the following people: Ms. Lisa A. Conte , Founder, CEO, Pres & Director (Age 63, Pay $722.54k) Mr. Jona...
Who are some of Jaguar Health's key competitors?
Some companies that are related to Jaguar Health include Greenwich LifeSciences (GLSI) , Evelo Biosciences (EVLO) , Daré Bioscience (DARE) , Sa...
What other stocks do shareholders of Jaguar Health own?
Based on aggregate information from My MarketBeat watchlists, some companies that other Jaguar Health investors own include Biocept (BIOC) , Sorr...
When will Jaguar Health release its earnings?
What is the ticker symbol for Jaguar Health?
Jaguar Health is scheduled to release its next quarterly earnings announcement on Thursday, August 12th 2021. View our earnings forecast for Jaguar Health.
What is Jaguar Health?
Jaguar Health trades on the NASDAQ under the ticker symbol "JAGX."
Is Jaguar Health a buy or sell company?
Jaguar Health, Inc. is a commercial stage pharmaceuticals company, which engages in the development of gastrointestinal products. The firm focuses on developing novel, plant-based, non-opioid, and sustainably derived prescription medicines for people and animals with GI distress, specifically chronic, debilitating diarrhea. It operates through the Human Health and Animal Health segments. The Human Health segment manufactures human products and the ongoing advertising of Mytesi, which is used for the symptomatic relief of non-infectious diarrhea in adults with HIV/AIDS on antiretroviral therapy. The Animal Health segment commercializes prescription and non-prescription products for companion and production animals. The company was founded by Lisa A. Conte on June 6, 2013 and is headquartered in San Francisco, CA.
Does Jaguar Health pay dividends?
Jaguar Health has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 1 buy rating, no hold ratings, and no sell ratings.
Jaguar Animal Health Seeks MUMS Designation from FDA for Canalevia (Crofelemer) for Treatment of Exercise-induced Diarrhea (EID) in Dogs
Jaguar Health does not currently pay a dividend.
Jaguar Health Announces Receipt by Napo Therapeutics of Small and Medium Enterprise (SME) Designation from the European Medicines Agency
In December of 2021, FDA conditionally approved Canalevia™-CA1 for treatment of chemotherapy-induced diarrhea in dogs, and the company expects Canalevia could receive FDA conditional approval, under the name Canalevia™-CA2, for treatment of EID in dogsSAN FRANCISCO, CA / ACCESSWIRE / February 16, 2022 / Jaguar Health, Inc.
Jaguar Health Completes Final Major Regulatory Filing for Conditional New Animal Drug Approval of Canalevia (Crofelemer) to Treat Exercise-induced Diarrhea in Dogs
SME status is an important designation for Italy-based Napo Therapeutics' rare/orphan disease business modelSAN FRANCISCO, CA and MILAN, ITALY / ACCESSWIRE / February 15, 2022 / Jaguar Health (NASDAQ:JAGX) and Napo Therapeutics S., an Italian corporation established by Jaguar Health in Milan, Italy, today announced that Napo Therapeutics has been granted Small and Medium Enterprise (SME) designation by the European Medicines Agency (EMA)..
Ideas
Canalevia™ would be first and only FDA-approved plant-based medicine for working dogs that suffer from diarrheaSAN FRANCISCO, CA / ACCESSWIRE / February 10, 2022 / Jaguar Health, Inc.
Profile
We see Jagx hit the 89% fib zone with a confirmed close of a 4hr bulllish engulfing candle at this area of confluence. this is a great contender for a bottom and we should see some green days off of it. happy trading Rigo
20 Stocks Moving in Thursday's Pre-Market Session
Jaguar Health, Inc. is a commercial stage pharmaceuticals company, which engages in the development of gastrointestinal products. The firm focuses on developing novel, plant-based, non-opioid, and sustainably derived prescription medicines for people and animals with GI distress, specifically chronic, debilitating diarrhea.
50 Biggest Movers From Yesterday
Gainers BTCS Inc. (NASDAQ: BTCS) rose 41% to $9.45 in pre-market trading after jumping 19% on Wednesday.
28 Stocks Moving In Wednesday's Mid-Day Session
Gainers electroCore, Inc. (NASDAQ: ECOR) shares jumped 64% to settle at $0.88 on Wednesday after the company's gammaCore nVNS device received FDA Breakthrough Designation for PTSD treatment.
15 Stocks Moving in Wednesday's Pre-Market Session
Gainers Immuron Limited (NASDAQ: IMRN) shares jumped 40.2% to $3.5887. Immuron received funding of A$6.2 ($4.45) million from the U.S Department of Defense to examine a dosing regimen for Travelan more suited for use by the military.
The Daily Biotech Pulse: Lilly Sings Metabolic Disorder Drug Pact, Moderna Reports Positive Flu Vaccine Data, Halozyme To Buy Back Shares
Gainers Kidpik Corp. (NASDAQ: PIK) rose 34.4% to $8.13 in pre-market trading after jumping more than 27% on Tuesday. Kidpik, last month, posted a Q3 loss of $0.22 per share.
What is Jaguar Health?
Here's a roundup of top developments in the biotech space over the last 24 hours.
What is dividend percentage?
Jaguar Health, Inc. is a commercial stage pharmaceuticals company, which engages in the development of gastrointestinal products. Its products include Canalevia, Equilevia, and Neonorm. It operates through the Human Health and Animal Health segments. The Human Health...
How to calculate restricted stock?
A company's dividend expressed as a percentage of its current stock price.
How often do exchanges report short interest?
To calculate, start with total shares outstanding and subtract the number of restricted shares. Restricted stock typically is that issued to company insiders with limits on when it may be traded. A company's dividend expressed as a percentage of its current stock price.
Who owns restricted shares of a company?
Percentage change in short interest from the previous report to the most recent report. Exchanges report short interest twice a month.
Does JAGX pay dividends?
Number of shares that are currently held by investors, including restricted shares owned by the company's officers and insiders as well as those held by the public.
JAGX Overview
JAGX is not currently paying a regular dividend.
Zen Score
Jaguar Health, Inc. is a commercial stage pharmaceuticals company, which engages in the development of gastrointestinal... read more
Due Diligence Checks
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how JAGX scored across 38 valuation, financial, forecast, performance, and dividend due diligence checks.
Profit margin
JAGX's profit margin has decreased... subscribe to Premium to read more.
Assets to liabilities
JAGX's cash and short-term investments... subscribe to Premium to read more.
Cash flow
JAGX's short-term assets ($24.01M) exceed... subscribe to Premium to read more.
